Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 71 | 1 | 92 | +22 |
| Shares | 17.5M | 147 | 41.0M | +23.5M (+134.4%) |
| Value | $42.9M | $0 | $120.2M | +$77.3M (+180.1%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (33)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (11)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Sessa Capital IM, L.P. | 3,661,237 | $8.97M |
| Miracle Mile Advisors, LLC | 30,300 | $74.0K |
| Barclays PLC | 29,541 | $72.0K |
| GM Advisory Group, Inc. | 20,000 | $49.0K |
| Principal Financial Group Inc | 11,801 | $29.0K |
| HRT Financial LP | 10,435 | $25.0K |
| Captrust Financial Advisors | 2,783 | $7.00K |
| Cutler Group LP | 1,700 | $4.00K |
| BNP Paribas Arbitrage, SA | 1,118 | $2.74K |
| O'Dell Group, LLC | 584 | $1.00K |
| Meridian Wealth Partners, LLC | 170 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Berman Capital Advisors, LLC | 147 | $0 |